Croatia vs Jordan: The number of people with susceptibility test result for rifampicin
Croatia
62
in 2021
Jordan
62
in 2021
Croatia rank
117th
Jordan rank
117th
The number of people with susceptibility test result for rifampicin over time
- Croatia
- Jordan
How they compare
Croatia currently reports 62 against 62 in Jordan, a difference of 0.
The two have swapped places 1 time across 5 shared years of data; in 2017 it was Croatia ahead.
Croatia ranks 117th and Jordan ranks 117th of 155 countries.
Across the 2 decades both report, Croatia averaged higher in 1 and Jordan in 1.
Head to head by decade
| Decade | Croatia | Jordan | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 128.33 | 84.33 | 44 | Croatia |
| 2020s | 31 | 86 | 55 | Jordan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Croatia or Jordan?
- Croatia, at 62 against 62 in Jordan as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Croatia and Jordan?
- 0, with Croatia ahead.
- How many years of comparable data are there for Croatia and Jordan?
- 5 years are reported by both, from 2017 to 2021.
- How do Croatia and Jordan rank globally for the number of people with susceptibility test result for rifampicin?
- Croatia ranks 117th and Jordan ranks 117th of 155 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid refreshes it automatically from the source and publishes the full history for both places.